The markets opened higher with the Dow climbing 60 points to 17,958 even as crude oil prices fell. Nasdaq gained 15 points to 4,953.
On the upside
Cvent (NYSE: CVT) will be acquired by Vista Equity Partners for a premium of approximately $1.65 billion in cash.
Weigao Orthopedic entered an exclusive 10-year agreement to sell, market and distribute Amedica (Nasdaq: AMDA) branded silicon nitrate spinal implants in China.
Celator Pharmaceuticals (Nasdaq: CPXX) reported positive data for VYXEOS Liposome for Injection.
On the downside
The Food and Drug Administration advised Chiasma (Nasdaq: CHMA) that its New Drug Application for the acromegaly treatment Mycapssa did not provide substantial evidence of efficacy to warrant approval and recommended and additional clinical trial.
Calumet Specialty Products Partners (Nasdaq: CLMT) warned of significant losses for the first quarter, suspended its quarterly cash dividend and priced a private placement of senior secured notes.
Rex Energy (Nasdaq: REXX) entered an exchange agreement with a holder of the company's preferred stock and senior secured second lien notes.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 gained 8 points to 2,088. Bitcoin added $1 to $426.
